Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal tolerance to E-selectin and response to systemic inflammation.

Kachi Illoh1, Catherine Campbell, Orieji Illoh

  • 1Department of Neurology, University of Texas Health Sciences Center, Houston, Texas 77030, USA. kachikwu.illoh@uth.tmc.edu

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|April 6, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Potentials and limitations of large-scale, individual-level mobile location data for food acquisition analysis.

Health & place·2025
Same author

Rebound hypercalcaemia timing is associated with cumulative weight-based denosumab dose for central giant cell granuloma treatment in children despite a dose weaning regimen.

Bone·2025
Same author

Assessment of Preoxygenation using Real-Time End-Tidal Oxygen Measurements Versus Single-Breath End-Tidal Oxygen Measurements in Healthy Volunteers.

Journal of the American College of Emergency Physicians open·2025
Same author

Effect of using virtual reality on fatigue and mental workload as key determinants of perceived stress in neonatal intensive care staff: A randomized controlled trial feasibility study and protocol.

Nursing in critical care·2025
Same author

Young adult reflections on life experiences following preterm birth: a cross-sectional descriptive study.

Archives of disease in childhood. Fetal and neonatal edition·2024

Mucosal tolerance to E-selectin, a protein involved in inflammation, can protect against stroke. This study identified effective doses and gene expression changes in the brain and spleen, offering potential therapeutic targets.

Area of Science:

  • Immunology
  • Neuroscience
  • Molecular Biology

Background:

  • E-selectin plays a role in inflammation and stroke pathogenesis.
  • Previous studies suggest mucosal tolerance to E-selectin may prevent stroke.
  • The optimal dose and underlying mechanisms of E-selectin-induced mucosal tolerance remain unclear.

Purpose of the Study:

  • To determine the effective dose range for inducing mucosal tolerance to E-selectin.
  • To investigate the molecular mechanisms of neuroprotection conferred by mucosal tolerance.
  • To analyze gene expression changes in response to E-selectin tolerance and inflammatory challenge.

Main Methods:

  • Induction of mucosal tolerance to E-selectin in spontaneously hypertensive rats (SHRs) via nasal instillation.

Related Experiment Videos

  • Dose-response assessment of E-selectin administration (0.1 to 5 microg).
  • Measurement of anti-E-selectin immunoglobulin G antibody production.
  • Gene expression profiling of brain and spleen tissues following lipopolysaccharide (LPS) exposure.

    • Main Results:

    • Mucosal tolerance to E-selectin was achieved with doses ranging from 0.1 to 5 microg.
    • A dose-dependent production of anti-E-selectin IgG antibodies was observed.
    • Distinct gene expression patterns were identified in the brain and spleen.
    • Key gene changes included insulin-like growth factors in the brain and downregulation of MHC class I molecules in the spleen.

    Conclusions:

    • Mucosal tolerance to E-selectin can be effectively induced within a specific dose range.
    • This tolerance modulates gene expression in the brain and spleen, offering insights into neuroprotection mechanisms.
    • Identified molecular targets may facilitate the development of novel therapeutic strategies for stroke prevention.